RWA Wealth Partners LLC Sells 560 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

RWA Wealth Partners LLC lowered its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 3.9% in the 4th quarter, Holdings Channel.com reports. The firm owned 13,732 shares of the financial services provider’s stock after selling 560 shares during the quarter. RWA Wealth Partners LLC’s holdings in iShares Biotechnology ETF were worth $1,865,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Glass Jacobson Investment Advisors llc raised its position in iShares Biotechnology ETF by 150.6% in the 3rd quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 122 shares during the period. Values First Advisors Inc. bought a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $43,000. Horizon Bancorp Inc. IN purchased a new position in iShares Biotechnology ETF during the 3rd quarter valued at $44,000. Tennessee Valley Asset Management Partners bought a new position in iShares Biotechnology ETF in the 4th quarter valued at $44,000. Finally, Column Capital Advisors LLC bought a new stake in shares of iShares Biotechnology ETF during the third quarter worth $49,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB opened at $128.02 on Wednesday. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $141.16. The company’s 50-day moving average price is $134.81 and its 200-day moving average price is $129.75.

iShares Biotechnology ETF Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were given a dividend of $0.126 per share. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.39%. The ex-dividend date was Thursday, March 21st.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.